REG - BATM Advanced Comm - Trading Update and Notice of Results

Batm Advanced CommunicationsAnnouncement

17/02/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220217:nRSQ9274Ba&default-theme=true

RNS Number : 9274B  BATM Advanced Communications Ld  17 February 2022

LEI: 213800FLQUB9J289RU66

17 February 2022

 

BATM Advanced Communications Limited

("BATM" or "the Group")

 

Trading Update and Notice of Results

 

BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for
networking solutions and medical laboratory systems, gives notice that the
Group will be announcing its results for the year ended 31 December 2021 on
Monday 28 February 2022.

 

The Group is delighted to announce that it expects to report full year revenue
and EBITDA for 2021 slightly ahead of market expectations (which were raised
during the year on 23 August 2021) reflecting strong growth from ongoing
operations* with increased revenue in both divisions. In particular, this has
been driven by significant growth in the Group's Diagnostics unit of the
Bio-Medical division.

 

Looking ahead, the Group entered the new year with a substantially higher
backlog from ongoing operations than at the same point of the prior year and
the strong momentum of 2021 has continued. Accordingly, the Group remains on
track to deliver significant growth for full year 2022 in line with market
expectations.

 

Further detail will be provided in the Group's full year results announcement
on 28 February 2022.

 

Presentations to analysts and investors

 

Dr Zvi Marom, Chief Executive Officer, and Moti Nagar, Chief Financial
Officer, will be holding presentations in London on the day of the results
for:

·    analysts at 9.00am GMT; and for

·    private shareholders at 5.30pm GMT.

 

To register to attend either presentation, please contact
laraapstein@luther.co.uk (mailto:laraapstein@luther.co.uk) .

 

 

* Excluding the contribution to 2021 and 2020 from NGSoft, a non-core
subsidiary that the Group sold in March 2021, and the contribution to 2020
from a significant contract to supply critical care ventilators, which was
exceptional in nature.

 

 

Enquiries:

 BATM Advanced Communications
 Dr Zvi Marom, Chief Executive Officer                          +972 9866 2525
 Moti Nagar, Chief Financial Officer

 Shore Capital
 Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory)  +44 20 7408 4050

 Luther Pendragon
 Harry Chathli, Claire Norbury                                  +44 20 7618 9100

 

 

Forward-looking statements

This document contains forward-looking statements. Those statements reflect
the current opinions, evaluations and estimations of the Group's management,
and are based on the current data regarding the Group's business as is
detailed in this document and in the Group's periodical, interim and immediate
reports. The Group does not undertake any obligation or make any
representation that actual results and events will be in line with those
statements, and stresses that they may differ materially from those
statements, due to changes in the Group's business, market, competition,
demand for the Group's products or services, general economic factors or other
factors that can influence the Group's business and results, and due to
information and factors that are currently unknown to the Group's management
and that, if known, would affect the management's opinions, evaluations or
estimations. The Group will report the actual results and events according to
its legal, accounting and regulatory obligations, and does not undertake any
other obligation to report them or their deviations from the forward-looking
statements, or to update any of the forward-looking statements in this
document or to report that it is not valid anymore.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTFLFSAFFIRLIF